All publications

Original Article · 2015

A contemporary analysis of Fournier gangrene using the National Surgical Quality Improvement Program

Kim SY, Dupree JM, Le BV, Kim DY, Zhao LC, Kundu SD

Urology · 2015

PubMed DOI PMID 25770725

Citation

Kim SY, Dupree JM, Le BV, Kim DY, Zhao LC, Kundu SD. A contemporary analysis of Fournier gangrene using the National Surgical Quality Improvement Program. Urology 2015; 85; 1052-6.

Abstract

To determine a nationwide contemporary description of surgical Fournier gangrene (FG) and necrotizing fasciitis of the genitalia (NFG) outcomes because historically reported mortality rates for FG and NFG are based on small single-institution studies from the 1980s and the 1990s. The National Surgical Quality Improvement Program is a risk-adjusted surgical database used by nearly 400 hospitals nationwide, which tracks preoperative, intraoperative, and 30-day postoperative clinical variables. Data are extracted from patient charts by an independent surgical clinical reviewer at each hospital. Using the National Surgical Quality Improvement Program data from 2005 to 2009, we calculated 30-day mortality rates and identified preoperative factors associated with increased mortality. A total of 650 patients were identified with surgery for FG or NFG. Fourteen patients with do not resuscitate orders placed preoperatively were excluded from analyses. For the remaining 636 patients, the overall 30-day mortality was 10.1% (64 of 636). Fifty-seven percent of patients (360 of 636) were men, 70% (446 of 636) were white, and 13% (81 of 636) were African American. Multivariate logistic regression indicated that increased age (odds ratio [OR], 1.041; P = .004), body mass index (OR, 1.045; P <.001), and preoperative white blood cell count (OR, 1.061; P = .001), and decreased platelet count (OR, 0.993; P <.001) were all associated with increased risk of death. We determined a surgical mortality rate for FG-NFG of 10.1%. This rate is about half of historically published estimates and similar to recent studies. The lower rate may indicate improvements in therapy. Increased age, body mass index, and white blood cell count, and decreased platelet count were all associated with an increased risk of 30-day mortality.

Key Points

  • Published in Urology in 2015.
  • Indexed in PubMed as PMID 25770725.
  • Mapped to Prosthetics (AUS/IPP), Stones & BPH, Outcomes, Methods & Education.
  • Abstract available from PubMed and rendered as static text on this page.

Clinical Relevance

This work belongs to the outcomes, methods, and education layer of the site, where measurement, registries, training, and patient-reported outcomes support clinical interpretation.

Related Publications